We are live on ! Find out more
SCP

Seizert Capital Partners Portfolio holdings

AUM $2.17B
1-Year Est. Return 11.2%
This Fund
S&P 500
This Quarter Est. Return
+4.18%
1 Year Est. Return
+11.2%
3 Year Est. Return
+58.29%
5 Year Est. Return
+75.11%
10 Year Est. Return
+297.99%
AUM
$2.78B
AUM Growth
+$58.1M
Cap. Flow
-$38.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
29.96%
Holding
208
New
27
Increased
47
Reduced
102
Closed
19

Top Sells

Rank Stock Value
1
MIDD icon
Middleby
MIDD
+$38.5M
2
AIG icon
American International
AIG
+$23.1M
3
RWT
Redwood Trust
RWT
+$23M
4
PH icon
Parker-Hannifin
PH
+$14.9M
5
AAPL icon
Apple
AAPL
+$9.56M

Sector Composition

Rank Sector Weight
1 Financials 25.11%
2 Technology 18.92%
3 Healthcare 14.3%
4 Industrials 10.5%
5 Communication Services 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$42.4M 1.52%
243,570
+1,506
+0.6% +$267K
CTXS
27
DELISTED
Citrix Systems Inc
CTXS
$41.3M 1.49%
469,607
-17,659
-4% -$1.5M
MSFT icon
28
Microsoft
MSFT
$3.45T
$41.3M 1.48%
482,496
-18,122
-4% -$1.49M
JNJ icon
29
Johnson & Johnson
JNJ
$618B
$40M 1.44%
286,368
+2,069
+0.7% +$288K
VMI icon
30
Valmont Industries
VMI
$9.3B
$39.8M 1.43%
240,055
-9,147
-4% -$1.49M
TT icon
31
Trane Technologies
TT
$100B
$39.5M 1.42%
442,457
+142,659
+48% +$12.6M
WU icon
32
Western Union
WU
$1.98B
$38.8M 1.39%
2,039,559
-77,285
-4% -$1.52M
PKG icon
33
Packaging Corp of America
PKG
$21.9B
$36.6M 1.31%
303,304
-11,214
-4% -$1.3M
DGX icon
34
Quest Diagnostics
DGX
$25.7B
$36.5M 1.31%
370,468
+24,488
+7% +$2.32M
C icon
35
Citigroup
C
$222B
$36.2M 1.3%
485,892
-22,953
-5% -$1.7M
ORCL icon
36
Oracle
ORCL
$374B
$33.6M 1.21%
710,127
+63,809
+10% +$3.13M
GS icon
37
Goldman Sachs
GS
$300B
$31.8M 1.14%
124,747
+1,829
+1% +$449K
BIIB icon
38
Biogen
BIIB
$30B
$31.4M 1.13%
98,500
-755
-0.8% -$242K
EG icon
39
Everest Group
EG
$14.5B
$30.8M 1.11%
139,292
-5,164
-4% -$1.16M
VZ icon
40
Verizon
VZ
$195B
$29.7M 1.07%
560,470
+117,644
+27% +$5.79M
AET
41
DELISTED
Aetna Inc
AET
$29.1M 1.04%
161,079
-25,728
-14% -$4.42M
CVS icon
42
CVS Health
CVS
$133B
$26.1M 0.94%
359,879
-118,322
-25% -$8.6M
HRB icon
43
H&R Block
HRB
$5.58B
$24.4M 0.88%
+929,288
New +$24.1M
WMT icon
44
Walmart Inc
WMT
$885B
$24.2M 0.87%
736,455
-195,981
-21% -$6M
NOC icon
45
Northrop Grumman
NOC
$77.1B
$24.1M 0.87%
78,596
-7,760
-9% -$2.33M
FLR icon
46
Fluor
FLR
$7.01B
$24M 0.86%
464,440
-14,110
-3% -$657K
EPC icon
47
Edgewell Personal Care
EPC
$1.25B
$23.7M 0.85%
+398,352
New +$25.1M
INTC icon
48
Intel
INTC
$455B
$23.7M 0.85%
512,426
-4,925
-1% -$215K
ELV icon
49
Elevance Health
ELV
$81.5B
$22.8M 0.82%
101,263
-20,354
-17% -$4.34M
CELG
50
DELISTED
Celgene Corp
CELG
$21.4M 0.77%
204,689
+119,168
+139% +$13.4M

Similar funds

Seizert Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Seizert Capital Partners held 208 positions worth $2.78B, up 2.1% from $2.72B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Seizert Capital Partners's Q4 2017 filing shows 27 new, 47 increased, 102 reduced and 19 closed positions. Its largest new stake was Edgewell Personal Care: 398,352 shares worth $23.7M. The largest sale was Middleby, an estimated $38.5M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Seizert Capital Partners's largest Q4 2017 buy was Edgewell Personal Care: 398,352 shares worth $23.7M.
  • Seizert Capital Partners added most to Celgene Corp in Q4 2017, an estimated $13.4M increase.
  • Seizert Capital Partners's biggest Q4 2017 reduction was Redwood Trust, cutting an estimated $23M.
  • Seizert Capital Partners fully exited Middleby in Q4 2017, selling an estimated $38.5M.
  • Seizert Capital Partners's ten largest holdings make up 30% of its $2.78B portfolio in Q4 2017.
  • Seizert Capital Partners opened 27 new positions and closed 19 in Q4 2017.
  • Seizert Capital Partners's portfolio value rose 2.1% quarter-over-quarter to $2.78B.

Based on Seizert Capital Partners's 13F filing for Q4 2017, filed 12 Feb 2018.